 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 64178/96951 (66%)
Visitors : 9475963
Online Users : 9992
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/126964
|
Title: | Growth inhibition and toxicity assessments of cis-3,4-diaryl-α-methylene-γ-butyrolactams in cultured human renal cancer cells and zebrafish embryos |
Authors: | Lee, Adam Shih-Yuan;Lin, Ta-Hsien;Liu, Yen-Yu;Wang, Yun-Hsin;Cheng, Shu-Chun;Li, Tao-Sheng;Sun, Chiao-Yin;Chen, Yau-Hung |
Keywords: | Butyrolactams;Renal cell carcinoma;Zebrafish |
Date: | 2025-01-07 |
Issue Date: | 2025-03-20 09:33:06 (UTC+8) |
Publisher: | Elsvier |
Abstract: | This study aimed to compare and evaluate the growth inhibition effects of eight previously synthesized compounds, cis-3,4-diaryl-α-methylene-γ-butyrolactams (compounds 1-8), on two human renal carcinoma cell (RCC) lines: CRL-1932 (rapid growth) and HTB-44 (slow growth). MTT assays and flow cytometry were conducted, revealing that compounds 5 and 6 had the potential to induce cell death in the slow-growing RCC cells (HTB-44), while compound 8 demonstrated effectiveness in both RCC lines (HTB-44 and CRL-1932). Additionally, a non-transformed HEK293 cell line and a transgenic zebrafish with a green fluorescent kidney Tg(wt1b:egfp) were used to assess the toxicities of compounds 5, 6, and 8. The findings suggested that compound 8 was relatively non-toxic compared to the others. Western blot analysis indicated that compounds 5, 6, and 8 may interact with the P53/mTOR pathways. Based on these results, we concluded that compound 8 exhibits RCC growth inhibition properties and has lower toxicity, making it a candidate for further investigation in mammalian models. |
Relation: | Biochimica et Biophysica Acta |
DOI: | 10.1016/j.bbagen.2025.130761 |
Appears in Collections: | [Graduate Institute & Department of Chemistry] Journal Article
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 14 | View/Open |
|
All items in 機構典藏 are protected by copyright, with all rights reserved.
|